Erez Chimovits, Director at LogicBio Therapeutics, Inc. (LOGC), bought 3,487,760 shares at $10.00 ($4.9M) on 2018-10-23, disclosed to the SEC on 2018-10-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,997,760 | $0 | 0.0% |
| 2 | $10.00 | 490,000 | $4.9M | 100.0% |
| Total | $1.40 avg | 3,487,760 | $4.9M | 100% |
| Filing → |
| LOGC | BUY | 2020-10-05 | $8.9M | — | Filing → |
| PHGE | BUY | 2019-12-20 | $36K | — | Filing → |
| PHGE | BUY | 2019-12-12 | $78K | — | Filing → |